Search | IOVS | ARVO Journals

Showing 1 – 20 of 68

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Exploring the Role of ANGPTL4 as a Stemness Marker in Uveal Melanoma

Sue L Choi; LINDA A CERNICHIARO-ESPINOSA; Emily Louie; Yinan Wang; Chuan He Yang; Deanna Parke; Matthew W Wilson; Lawrence Pfeffer

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2259.

ARVO Annual Meeting Abstract June 2024

International Retinoblastoma Liquid Biopsy Consortium (IRB-LBC): A Multi-Center, Multi-National Collaborative Study on Aqueous Humor as a Liquid Biopsy Tool for Retinoblastoma

Brianne Brown; Drishti Pandya; Liya Xu; Carol Shields; Hans E Grossniklaus; Andrew W Stacey; Alison Skalet; Matthew W Wilson; Janice Lasky Zeid; Armin Afshar; Brenda L Gallie; Eric Hansen; Junne Kamihara; Bhavana Chawla; Talita de Toledo Lima; Jesse L Berry

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):464.

ARVO Annual Meeting Abstract June 2024

Clinical Features of Uveal Melanoma in Patients of African Descent

Benjamin A King; LINDA A CERNICHIARO-ESPINOSA; Sue Choi; Lawrence Pfeffer; Matthew W Wilson

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2240.

ARVO Annual Meeting Abstract June 2024

Immunological profiling of liver metastasis of uveal melanoma

Matthew W Wilson; LINDA A CERNICHIARO-ESPINOSA; Sue Choi; Stephanie Allen -Winters; Chuan He Yang; Lawrence Pfeffer

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4277.

ARVO Annual Meeting Abstract June 2024

Integrating Clinical data, RNA sequencing, Multi-Omics Analysis, and RNA-In Situ Hybridization for Spatial Profiling of Uveal Melanoma

LINDA A CERNICHIARO-ESPINOSA; Sue Choi; Chuan He Yang; Lawrence Pfeffer; Matthew W Wilson

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2265.

ARVO Annual Meeting Abstract June 2023

Clinical characteristics and outcomes in young patients with uveal melanoma from the mid-south United States

Ilyse Kornblau; Benjamin A King; LINDA A A CERNICHIARO-ESPINOSA; Matthew W Wilson

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):898.

ARVO Annual Meeting Abstract June 2023

Anterior segment complications and globe salvage following intravitreal or periocular chemotherapy for intraocular retinoblastoma

Benjamin King; LINDA A A CERNICHIARO-ESPINOSA; Cigdem Ozturk; Rachel C Brennan; Matthew W Wilson; Mary Ellen Hoehn

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1273.

ARVO Annual Meeting Abstract June 2023

Co-expression of ANGPTL-4 and STAT3 in liver metastasis of uveal melanoma

LINDA A A CERNICHIARO-ESPINOSA; Matthew W Wilson; Emily Louie; Denna Parker; Chuan He Yang; Yinan Wang; Lawrence M Pfeffer

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1319.

ARVO Annual Meeting Abstract June 2023

Predicting Survival from Choroidal Melanoma Utilizing Multilayer Perceptron Artificial Neural Network

Brian Firestone; Zain Hussain; Asad Loya; Matthew W Wilson; Siamak Yousefi

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):893.

ARVO Annual Meeting Abstract June 2023

Intraocular MDMX Inhibition by ALRN-6924: A Targeted Strategy to Reactivate p53 in Retinoblastoma

Matthew W Wilson; Elizabeth Stewart; Michael A. Dyer; Allen Annis; Rachel C Brennan

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1272.

ARVO Annual Meeting Abstract June 2023

Ethnic and Socioeconomic Factors Associated with Locally Advanced Retinoblastoma at a Single Center: A Retrospective Study from 1999-2021.

Edward Simpson; Benjamin A King; Carlos Rodriguez-Galindo; Rachel C Brennan; Matthew W Wilson

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3272.

ARVO Annual Meeting Abstract June 2022

Targeting Bromodomain of Brg-1 in Uveal Melanoma Cells with Small Molecule PFI-3: A Possible Novel Therapy

Matthew W Wilson; Emily Louie; Chuanhe Yang; Yinan Wang; Lawrence M Pfeffer

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1460.

ARVO Annual Meeting Abstract June 2021

Activation of the STAT3 signaling pathway in Metastatic Uveal Melanoma

Matthew W Wilson; Sara Parker; Michelle Sims; Yinan Wang; Chaun He Yang; Lawrence M Pfeffer

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2866.

ARVO Annual Meeting Abstract June 2021

Intravitreal Carboplatin as Salvage Treatment for Progressive Vitreous Disease in Retinoblastoma: a Phase I Clinical Trial

Benjamin King; Matthew W Wilson; Rachel Brennan

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2855.

ARVO Annual Meeting Abstract June 2021

Intravitreal Chemotherapy Eligibility and Ocular Survival for Advanced Retinoblastoma

Jacquelyn Laplant; Matthew W Wilson; Fang Wang; Haitao Pan; Benjamin A King; Rachel Brennan

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2851.

ARVO Annual Meeting Abstract June 2020

Spontaneous Retinoblastoma (RB) in Patient Induced Pluripotent Stem Cell (iPSC) Derived Retinal Organoid

Matthew W Wilson; Rachel C Brennan; Jackie L Norrie; Anjana Nityanandam; Xiang Chen; Elizabeth Stewart; Lyra Griffiths; Jiakun Zhang; Dianna A Johnson; Michael Dyer

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1396.

ARVO Annual Meeting Abstract June 2020

Combined Iridectomy and Brachytherapy: A Two-Stage Approach for the Treatment of Unresectable Iris Melanomas

Nikolas Hopkins; Caroline Awh; Benjamin King; Matthew W Wilson

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3617.

ARVO Annual Meeting Abstract June 2020

Changing Practice Patterns in Conjunctival Malignant Melanoma

Ilyse Kornblau; Matthew W Wilson

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4668.

ARVO Annual Meeting Abstract July 2019

The Retinoblastoma Tumor Microenvironment Contributes to Drug Resistance

Matthew W Wilson; Zachary K. Goldsmith; M Robert Brouner; Rachel C Brennan; Benjamin A King; Vanessa Marie Morales-Tirado

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2317.

ARVO Annual Meeting Abstract July 2019

In search for the RGC lineage: characterization of R28 cells and the expression of RGC markers

Nikolas Hopkins; Zachary K. Goldsmith; Monica M Jablonski; Matthew W Wilson; Gail M Seigel; Vanessa Marie Morales

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4861.

1 2 3 4

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Exploring the Role of ANGPTL4 as a Stemness Marker in Uveal Melanoma

International Retinoblastoma Liquid Biopsy Consortium (IRB-LBC): A Multi-Center, Multi-National Collaborative Study on Aqueous Humor as a Liquid Biopsy Tool for Retinoblastoma

Clinical Features of Uveal Melanoma in Patients of African Descent

Immunological profiling of liver metastasis of uveal melanoma

Integrating Clinical data, RNA sequencing, Multi-Omics Analysis, and RNA-In Situ Hybridization for Spatial Profiling of Uveal Melanoma

Clinical characteristics and outcomes in young patients with uveal melanoma from the mid-south United States

Anterior segment complications and globe salvage following intravitreal or periocular chemotherapy for intraocular retinoblastoma

Co-expression of ANGPTL-4 and STAT3 in liver metastasis of uveal melanoma

Predicting Survival from Choroidal Melanoma Utilizing Multilayer Perceptron Artificial Neural Network

Intraocular MDMX Inhibition by ALRN-6924: A Targeted Strategy to Reactivate p53 in Retinoblastoma

Ethnic and Socioeconomic Factors Associated with Locally Advanced Retinoblastoma at a Single Center: A Retrospective Study from 1999-2021.

Targeting Bromodomain of Brg-1 in Uveal Melanoma Cells with Small Molecule PFI-3: A Possible Novel Therapy

Activation of the STAT3 signaling pathway in Metastatic Uveal Melanoma

Intravitreal Carboplatin as Salvage Treatment for Progressive Vitreous Disease in Retinoblastoma: a Phase I Clinical Trial

Intravitreal Chemotherapy Eligibility and Ocular Survival for Advanced Retinoblastoma

Spontaneous Retinoblastoma (RB) in Patient Induced Pluripotent Stem Cell (iPSC) Derived Retinal Organoid

Combined Iridectomy and Brachytherapy: A Two-Stage Approach for the Treatment of Unresectable Iris Melanomas

Changing Practice Patterns in Conjunctival Malignant Melanoma

The Retinoblastoma Tumor Microenvironment Contributes to Drug Resistance

In search for the RGC lineage: characterization of R28 cells and the expression of RGC markers

To View More...

You must be signed into an individual account to use this feature.